145 related articles for article (PubMed ID: 3193214)
21. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
Weber W; Weber J; Senekowitsch-Schmidtke R
Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
[TBL] [Abstract][Full Text] [Related]
22. Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG.
Ezziddin S; Sabet A; Ko YD; Xun S; Matthies A; Biersack HJ
Radiat Oncol; 2012 Jan; 7():8. PubMed ID: 22277577
[TBL] [Abstract][Full Text] [Related]
23. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
Mairs RJ; Cunningham SH; Russell J; Armour A; Owens J; McKellar K; Gaze MN
J Nucl Med; 1995 Jun; 36(6):1088-95. PubMed ID: 7769433
[TBL] [Abstract][Full Text] [Related]
24. Preliminary results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid tumors.
Colombo L; Vignati A; Lomuscio G; Dottorini ME
J Nucl Biol Med (1991); 1991; 35(4):352-4. PubMed ID: 1823856
[TBL] [Abstract][Full Text] [Related]
25. Use of m-[131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma.
Krempf M; Lumbroso J; Mornex R; Brendel AJ; Wemeau JL; Delisle MJ; Aubert B; Carpentier P; Fleury-Goyon MC; Gibold C
J Clin Endocrinol Metab; 1991 Feb; 72(2):455-61. PubMed ID: 1991814
[TBL] [Abstract][Full Text] [Related]
26. Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
Bomanji J; Britton KE; Ur E; Hawkins L; Grossman AB; Besser GM
Nucl Med Commun; 1993 Oct; 14(10):856-61. PubMed ID: 8233228
[TBL] [Abstract][Full Text] [Related]
27. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutic possibilities in metastatic pheochromocytoma].
Vierhapper H; Raber W
Zentralbl Chir; 1997; 122(6):494-7. PubMed ID: 9334119
[TBL] [Abstract][Full Text] [Related]
29. [Internal radiation therapy for malignant neoplasm].
Yokoyama K; Kinuya S; Tonami N
Gan To Kagaku Ryoho; 1999 May; 26(6):768-74. PubMed ID: 10410145
[TBL] [Abstract][Full Text] [Related]
30. [131I]MIBG as a first line treatment in advanced neuroblastoma.
Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
[TBL] [Abstract][Full Text] [Related]
31. External beam radiation therapy (EBRT) for patients with malignant pheochromocytoma and non-head and -neck paraganglioma: combination with 131I-MIBG.
Fishbein L; Bonner L; Torigian DA; Nathanson KL; Cohen DL; Pryma D; Cengel KA
Horm Metab Res; 2012 May; 44(5):405-10. PubMed ID: 22566196
[TBL] [Abstract][Full Text] [Related]
32. Scintigraphy and treatment of medullary carcinoma of the thyroid with iodine-131 metaiodobenzylguanidine.
Clarke SE; Lazarus CR; Edwards S; Murby B; Clarke DG; Roden TM; Fogelman I; Maisey MN
J Nucl Med; 1987 Dec; 28(12):1820-5. PubMed ID: 3681441
[TBL] [Abstract][Full Text] [Related]
33. Treatment of malignant pheochromocytoma with a new radiopharmaceutical.
Sisson J; Shapiro B; Beierwaltes WH; Nakajo M; Glowniak J; Mangner T; Carey JE; Swanson DP; Copp J; Satterlee W
Trans Assoc Am Physicians; 1983; 96():209-17. PubMed ID: 6679954
[TBL] [Abstract][Full Text] [Related]
34. Iodine-131-MIBG therapy of a patient with carcinoid liver metastases.
Prvulovich EM; Stein RC; Bomanji JB; Ledermann JA; Taylor I; Ell PJ
J Nucl Med; 1998 Oct; 39(10):1743-5. PubMed ID: 9776280
[TBL] [Abstract][Full Text] [Related]
35. [Use of 131I-meta-iodobenzylguanidine in pediatric oncology].
Treuner J
Nuklearmedizin; 1985 Feb; 24(1):26-8. PubMed ID: 4000978
[TBL] [Abstract][Full Text] [Related]
36. Radiochemical purity of iodine-131 labelled metaiodobenzylguanidine infusion fluids: a report from clinical practice.
Wafelman AR; Suchi R; Hoefnagel CA; Beijnen JH
Eur J Nucl Med; 1993 Jul; 20(7):614-6. PubMed ID: 8370383
[TBL] [Abstract][Full Text] [Related]
37. Treatment of neuroblastoma with 131I-metaiodobenzylguanidine: experience of the Münster/Kassel Group.
Fischer M; Wehinger H; Kraus C; Ritter J; Schröter W
Med Pediatr Oncol; 1987; 15(4):196-8. PubMed ID: 3657707
[TBL] [Abstract][Full Text] [Related]
38. Radiochemical stability during infusion of 131I-labelled metaiodobenzylguanidine for therapeutic use.
Wafelman AR; Hoefnagel CA; Beijnen JH
Nucl Med Commun; 1993 Sep; 14(9):819-22. PubMed ID: 8233249
[TBL] [Abstract][Full Text] [Related]
39. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
[TBL] [Abstract][Full Text] [Related]
40. [Iodobenzylguanide-131 therapy as first choice in non-metastasized neuroblastoma].
De Kraker J; Hoefnagel CA; Caron HN; Vos A; Bras J; Greve JC
Ned Tijdschr Geneeskd; 1996 Oct; 140(40):1997-2000. PubMed ID: 8965930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]